Senior insider sale
EVP and Chief Legal Officer at ULTRAGENYX PHARMACEUTICAL INC. — senior position signals high conviction
$314.3K
14.15K shares
What this filing means
PARSCHAUER KARAH HERDMAN plans to sell 14.15K shares of ULTRAGENYX PHARMACEUTICAL INC. valued at approximately $314.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/6/2026ACC: 0001950047-26-002334
Officer· EVP and Chief Legal Officer
Since Mar 2026
14.15K
Shares to sell
$314.3K
Approx. market value
6.02K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months2
Performance Shares
Not Applicable
3/1/2024
688.00Restricted Stock
Not Applicable
3/1/2024
5.33KTotal acquired6.02K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/1/2024 | Performance Shares Not Applicable | 688.00 | — |
3/1/2024 | Restricted Stock Not Applicable | 5.33K | — |
| Total | 6.02K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
8.13K
Market value
$185.5K
3/2/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
6.02K
Market value
$128.8K
3/6/2026
Total
Units
14.15K
Value
$314.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/2/2026 | 8.13K | $185.5K | — | Completed |
| Planned — Approximate Date | ||||
3/6/2026 | 6.02K | $128.8K | NASDAQ | Planned |
| Total | 14.15K | $314.3K | ||